Fishtech, BacklotCars, Bardavon named to Forbes’ 2020 best startup employers list
March 10, 2020 | Startland News Staff
A trio of fast-growing Kansas City companies are among the 500 best startup employers in the nation, according to a new ranking from Forbes.
Gary Fish, Fishtech Group
Fishtech Group — one of Startland News’ Kansas City Startups to Watch in 2020 — lead the local honorees at No. 277 on Forbes’ list.
BacklotCars was ranked at No. 339, followed by Bardavon Health Innovations at No. 439.
Click here to see the full list of America’s Best Startup Employers for 2020.
“Those who are drawn to [working at] early-stage companies may have different professional priorities than those at more established firms, but the qualities they value most in employers are surprisingly similar,” the Forbes report read.
Such values include a clear mission, learning and development opportunities, transparency, and a flexible structure, according to the report. The top 500 list was compiled by evaluating 2,500 American businesses with at least 50 employees on three criteria: employer reputation, employee satisfaction and growth.
High-end amenities and cutting-edge office space also likely help.
Fishtech, a rapidly growing cyber security firm, boasts a sprawling Martin City campus with a more than $10 million cyber defense center. BacklotCars, which offers a wholesale platform for auto dealers, relocated in 2019 to fill a full floor of the newly renovated Lightwell building in downtown Kansas City.
Click here to take a closer look at Fishtech’s headquarters.
Matt Condon, Bardavon
For Bardavon, the recognition was unexpected, said Matt Condon, the healthcare startup’s CEO.
“This was a surprise to us. However, we unapologetically expect that Bardavon will continue to be recognized as a national market force for evolving and improving healthcare,” he said. “Because of our unique mission to optimize outcomes by focusing on clinical data and disintermediating the claims process through technology and transparency, we have been able to recruit some of the best talent in the country to our Bardavon team.”
Bardavon is one of 62 healthcare startups and one of only nine healthcare startups in the Midwest; the rest are located on the east or west coasts, the company emphasized.
Bardavaon was named one of Startland News’ Kansas City Startups to Watch in 2018.
Featured Business
2020 Startups to Watch
stats here
Related Posts on Startland News
Best in show: Bar K vies for USA Today’s dog bar prize; here’s how a shared love of dogs is pushing expansion
The human-dog bond — and a desire to embrace it at places like Bar K’s innovative bar, restaurant, and dog park experience — is stronger than today’s often partisan and divisive climate, said David Hensley. “It doesn’t matter your political affiliations … where you’re from, your socioeconomic status,” he said. “Everybody loves dogs, and that…
Firm with deep KC ties wins Small Business of the Year thanks to tenacity, hyperlocal focus
Editor’s note: The Greater Kansas City Chamber of Commerce is a non-financial partner of Startland News, which serves as the media partner for the Small Business Superstars program. A decades-long commitment to Kansas City clients — and the belief that rising tides lift all ships — helped propel Walz Tetrick Advertising to the award stage…
How this genre-hopping KC musician is fighting back against digitized entertainment
A former college football star, Keelon Vann often found himself “running on fumes” as he chased his passion on the field — and on key. “I’d be up playing guitar until 3 a.m., which is not a joke, and somehow make it to 5:30 a.m. workouts the next day,” said Vann, a quarterback at Piper High…
New collaboration will help OP startup 3D bioprint, scale its next-gen biotech solution
A Kansas biotech startup’s new manufacturing partner will boost efforts to automate and mass produce Ronawk’s headline-grabbing Bio-Block technology — a platform that has already accelerated medical advancements in tissue therapy. “Collaboration is critical for turning research advances into commercial therapies rapidly. The complexity and diversity of modalities is so big that nobody can do…